A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model

NHLBI funding policies. Enhancing stability, predictability, and cost control.

C Lenfant · Circulation · 1994 · 764 citations

Public Finance, Business, Economic Analysis +3

Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor

Thomas Girard, Louise A. Warren, William Novotny et al. · Nature · 1989 · 478 citations

Thrombosis, Lipoprotein-associated Coagulation Inhibitor, Biochemistry +8

Heparin induces release of extrinsic: Coagulation pathway inhibitor (EPI)

Per Morten Sandset, Ulrich Abildgaard, Metre Lie Larsen · Thrombosis Research · 1988 · 388 citations

Thrombosis, Medicine, Hematology +5

Cloning and characterization of a cDNA coding for the lipoprotein-associated coagulation inhibitor shows that it consists of three tandem Kunitz-type inhibitory domains.

Tze-Chein Wun, K K Kretzmer, Thomas Girard et al. · Journal of Biological Chemistry · 1988 · 327 citations · Full text

Histocompatibility, Lipoprotein-associated Coagulation Inhibitor, Laboratory Immunology +18

Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation

LV Rao, S I Rapaport · Blood · 1987 · 202 citations · Full text